Physician profile
John N Grady
NPI 1871933291
$1,506.55
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $149 · 2021: $224 · 2022: $206 · 2023: $253 · 2024: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $425.36 | 2019-2024 | Xarelto |
| Pfizer INC. | $334.17 | 2019-2023 | |
| Ucb, INC. | $177.49 | 2022-2024 | Briviact |
| Novartis Pharmaceuticals Corporation | $114.18 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $58.54 | 2019 | |
| Alexion Pharmaceuticals, INC. | $55.17 | 2024 | Ultomiris |
| Lexicon Pharmaceuticals, INC. | $55.04 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.13 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $51.65 | 2024 | Terlivaz |
| Abbvie INC. | $38.83 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $35.74 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $18.03 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.38 | 2022 | |
| Boston Scientific Corporation | $15.96 | 2024 | Watchman Access System |
| Medtronic, INC. | $14.63 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $14.21 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.79 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.25 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Grady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.